Barr Laboratories News

Developing a game plan when investing in healthcare can be a daunting task. Searching for intrinsic value between pharmaceutical makers, biotechnology companies and healthcare providers can lead investor to ...

Israeli stocks fell on Thursday as the Tel Aviv Stock Exchange reopened after the Jewish New Year holiday, having missed the past three volatile trading days on Wall Street.

Last week the Rule Breakers pick announced that the European Union health care authorities had recommended that its enzyme replacement therapy Kuvan be approved for marketing.

Only a little less than two weeks after proclaiming it would make expanding into the generic-drug business one of its main near-term objectives, Sanofi raised its bid on Monday to acquire Czech generic ...

It'll make inroads into Europe with the acquisition of Barr Pharmaceuticals , and now it's moving into Japan.

Boomer generation women are less prepared than men for the physical changes associated with menopause that can affect sex, a U.S. survey indicates.

When a company stumbles, it's often a great opportunity for competitors to step in and fill the void.

The Food and Drug Administration has won the latest installment of its grudge match with Teva Pharmaceuticals over the 180-day exclusivity period for generic versions of Johnson & Johnson 's Risperdal.

ARTEL , a provider of liquid-handling quality assurance, opened an office in Montral, Qubec, Canada to meet growing demand for its liquid handling quality-assurance products and services in the region.

The company has decided to hold onto the branded-drug business. And that's probably a good thing.

In the 30 years since they founded Sound Shore Management in Greenwich, Conn., Harry Burn and Gibbs Kane have seen all kinds of markets.

The Federal Trade Commission requested additional information from Teva Pharmaceutical Industries Ltd.

A little bit of courtroom finagling has opened up the Alzheimer's drug market to a slew of new competitors.

Mylan Inc. today announced that its subsidiary Alphapharm Pty Limited won a favorable decision in patent litigation against it and Barr Laboratories Inc.

Barr Pharmaceuticals and Mylan got a court to overturn Johnson & Johnson's patent on its Alzheimer's drug, Razadyne.

Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc., received final approval from the U.S. Food & Drug Administration to manufacture and market a generic version of Ortho ...

Dublin drug firm takes action against US rival Dublin drug company Azur Pharma , led by former Elan executive Samus Mulligan, has taken legal action against Barr Laboratories in the US over the American firm's ...

The Food and Drug Administration said it was working to amend the Tysabri label after two cases of the potentially fatal brain infection, progressive multifocal leukoencephalopathy , were reported in Europe.

Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Azur Pharma International in connection with its FazaClo orally ...